KLRK1 and neoplasm: During tumor immunosurveillance, the expression of MICA, MICB, and ULBP on tumor cells can be recognized by NKG2D, a NK-like activating receptor (NKR) expressed on γδT cells, particularly in Vγ9Vδ2 subset (43).